Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer

BACKGROUND: Current cancer immunotherapies have made tremendous impacts but generally lack high response rates, especially in ovarian cancer. New therapies are needed to provide increased benefits. One understudied approach is to target the large population of immunosuppressive tumor-associated macr...

Descripción completa

Detalles Bibliográficos
Autores principales: Glass, Evan B., Hoover, Alyssa A., Bullock, Kennady K., Madden, Matthew Z., Reinfeld, Bradley I., Harris, Whitney, Parker, Dominique, Hufnagel, Demetra H., Crispens, Marta A., Khabele, Dineo, Rathmell, W. Kimryn, Rathmell, Jeffrey C., Wilson, Andrew J., Giorgio, Todd D., Yull, Fiona E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074180/
https://www.ncbi.nlm.nih.gov/pubmed/35513776
http://dx.doi.org/10.1186/s12885-022-09612-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074180/
https://www.ncbi.nlm.nih.gov/pubmed/35513776
http://dx.doi.org/10.1186/s12885-022-09612-2

Ejemplares similares